Bilirubin levels predict malignancy in patients with obstructive jaundice

Hurtuk, 2010, Pancreaticoduodenectomis in patients without periampullary lesions: lesions that masquerade as cancer, Am J Surg, 199, 372, 10.1016/j.amjsurg.2009.09.011 Kassahun, 2009, Spectrum of benign lesions mimicking a malignant stricture at the liver hilum, Rev Recent Clin Trials, 4, 185, 10.2174/157488709789957547 Morris-Stiff, 2009, CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease, Hepatobiliary Pancreat Dis Int, 8, 620 Ong, 2008, Elevation of carbohydrate antigen 19-9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration, Dig Dis Sci, 53, 3213, 10.1007/s10620-008-0289-8 Sundeep, 2007, Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study, HPB, 9, 373, 10.1080/13651820701504207 Al-Mofleh, 2004, Biochemical and radiological predictors of malignant biliary strictures, World J Gastroenterol, 10, 1504, 10.3748/wjg.v10.i10.1504 Bain, 2000, Prospective study of biliary strictures to determine predictors of malignancy, Can J Gastroenterol, 14, 397, 10.1155/2000/467567 Mansfield, 2006, Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy – implications for timing of resectional surgery and use of biliary drainage, HPB, 8, 442, 10.1080/13651820600919860 Leelawat, 2009, Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy, BMC Gastroenterol, 9, 30, 10.1186/1471-230X-9-30 Marrelli, 2009, CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions, Am J Surg, 198, 333, 10.1016/j.amjsurg.2008.12.031 Li, 2009, Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma, Dig Liver Dis, 41, 605, 10.1016/j.dld.2008.11.010 Romagnuolo, 2003, Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease, Ann Intern Med, 7, 547, 10.7326/0003-4819-139-7-200310070-00006 Park, 2004, Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP, Radiology, 233, 234, 10.1148/radiol.2331031446 Adamek, 2000, Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study, Lancet, 15, 190, 10.1016/S0140-6736(00)02479-X Schick, 2008, Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangiopancreatography with intraductal ultrasonography and abdominal ultrasound, Eur J Nucl Med Mol Imaging, 35, 1775, 10.1007/s00259-008-0818-x Garrow, 2007, Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction, Clin Gastroenterol Hepatol, 5, 616, 10.1016/j.cgh.2007.02.027 Andersson, 2005, MRI combined with MR cholangiopancreatography versus helical CT in the evaluation of patients with suspected periampullary tumours: a prospective comparative study, Acta Radiol, 46, 16, 10.1080/02841850510016018